Extended-spectrum antibodies protective against carbapenemase-producing Enterobacteriaceae

Journal of Antimicrobial Chemotherapy

Volumn 71, Issue 4, 2016, Pages 927-935

  Skurnik, David ^a   Roux, Damien ^a   Pons, Stephanie ^a   Guillard, Thomas ^a   Lu, Xi ^a   Cywes Bentley, Colette ^a   Pier, Gerald B ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALGINIC ACID; AMIKACIN; ANTIBODY; AZTREONAM; CARBAPENEM DERIVATIVE; CARBAPENEMASE; CIPROFLOXACIN; COLISTIN; DOXYCYCLINE; GENTAMICIN; METALLO BETA LACTAMASE; MINOCYCLINE; MONOCLONAL ANTIBODY; N ACETYLGLUCOSAMINE; POLY (BETA 1,6) N ACETYLGLUCOSAMINE; POLYCLONAL ANTIBODY; POLYMYXIN B; TIGECYCLINE; UNCLASSIFIED DRUG; VIRULENCE FACTOR; BACTERIAL PROTEIN; BACTERIAL VACCINE; BACTERIUM ANTIBODY; BETA GLUCAN; BETA LACTAMASE; POLY-N-ACETYL-1-6-GLUCOSAMINE;

ALG GENE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; ASSAY; BACTERIAL GENE; BACTERIAL PERITONITIS; BACTERIAL STRAIN; BIOFILM; CARBAPENEMASE PRODUCING ENTEROBACTERIACEAE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; ENTEROBACTER CLOACAE; ESCHERICHIA COLI; FEMALE; GENE INACTIVATION; GENE LOCUS; GRAM NEGATIVE BACTERIUM; IN VITRO STUDY; IN VIVO STUDY; KLEBSIELLA PNEUMONIAE; MOUSE; NONHUMAN; OPSONOPHAGOCYTOSIS KILLING ASSAY; PGA GENE; ANIMAL; BIOSYNTHESIS; DRUG EFFECTS; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; ENZYMOLOGY; GENETICS; IMMUNOLOGY; MICROBIOLOGY;

ANIMALS; ANTIBODIES, BACTERIAL; BACTERIAL PROTEINS; BACTERIAL VACCINES; BETA-GLUCANS; BETA-LACTAMASES; BIOFILMS; DRUG RESISTANCE, BACTERIAL; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; MICE; VIRULENCE FACTORS;

EID: 84964388266     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkv448     Document Type: Article

References (33)

1. McKenney D, Hubner J, Muller E et al. The ica locus of Staphylococcus epidermidis encodes production of the capsular polysaccharide/adhesin. Infect Immun 1998; 66: 4711-20.
2. Wang X, Preston JF 3rd, Romeo T. The pgaABCD locus of Escherichia coli promotes the synthesis of a polysaccharide adhesin required for biofilm formation. J Bacteriol 2004; 186: 2724-34.
3. Cywes-Bentley C, Skurnik D, Zaidi T et al. Antibody to a conserved antigenic target is protective against diverse prokaryotic and eukaryotic pathogens. Proc Natl Acad Sci USA 2013; 110: E2209-18.
4. Skurnik D, Davis MR Jr, Benedetti D et al. Targeting pan-resistant bacteria with antibodies to a broadly conserved surface polysaccharide expressed during infection. J Infect Dis 2012; 205: 1709-18.
5. Cerca N, Maira-Litran T, Jefferson KK et al. Protection against Escherichia coli infection by antibody to the Staphylococcus aureus poly-N-acetylglucosamine surface polysaccharide. Proc Natl Acad Sci USA 2007; 104: 7528-33.
6. Bentancor LV, O'Malley JM, Bozkurt-Guzel C et al. Poly-N-acetyl-bβ-(1-6)-glucosamine is a target for protective immunity against Acinetobacter baumannii infections. Infect Immun 2012; 80: 651-6.
7. Roux D, Pier GB, Skurnik D. Magic bullets for the 21st century: the reemergence of immunotherapy for multi-and pan-resistant microbes. J Antimicrob Chemother 2012; 67: 2785-7.
8. Woerther PL, Burdet C, Chachaty E et al. Trends in human fecal carriage of extended-spectrum bβ-lactamases in the community: toward the globalization of CTX-M. Clin Microbiol Rev 2013; 26: 744-58.
9. Wailan AM, Paterson DL. The spread and acquisition of NDM-1: a multifactorial problem. Expert Rev Anti Infect Ther 2014; 12: 91-115.
10. Rasheed JK, Kitchel B, Zhu W et al. New Delhi metallo-blactamase-producing Enterobacteriaceae, United States. Emerg Infect Dis 2013; 19: 870-8.
11. KPC-harboring IncI2 plasmid and its dissemination in New Jersey and New York hospitals. Antimicrob Agents Chemother 2013; 57: 5019-25.
12. Datsenko KA, Wanner BL. One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc Natl Acad Sci USA 2000; 97: 6640-5.
13. Liberati NT, Urbach JM, Miyata S et al. An ordered, nonredundant library of Pseudomonas aeruginosa strain PA14 transposon insertion mutants. Proc Natl Acad Sci USA 2006; 103: 2833-8.
14. Pier GB, Boyer D, Preston M et al. Human monoclonal antibodies to Pseudomonas aeruginosa alginate that protect against infection by both mucoid and nonmucoid strains. J Immunol 2004; 173: 5671-8.
15. Kelly-Quintos C, Cavacini LA, Posner MR et al. Characterization of the opsonic and protective activity against Staphylococcus aureus of fully human monoclonal antibodies specific for the bacterial surface polysaccharide poly-N-acetylglucosamine. Infect Immun 2006; 74: 2742-50.
16. Kropec A, Maira-Litran T, Jefferson KK et al. Poly-N-acetylglucosamine production in Staphylococcus aureus is essential for virulence in murine models of systemic infection. Infect Immun 2005; 73: 6868-76.
17. Gening ML, Maira-Litran T, Kropec A et al. Synthetic bβ-(1→6)-linked N-acetylated and nonacetylated oligoglucosamines used to produce conjugate vaccines for bacterial pathogens. Infect Immun 2010; 78: 764-72.
18. Kaplan JB, Velliyagounder K, Ragunath C et al. Genes involved in the synthesis and degradation of matrix polysaccharide in Actinobacillus actinomycetemcomitans and Actinobacillus pleuropneumoniae biofilms. J Bacteriol 2004; 186: 8213-20.
19. Fazekas E, Kandra L, Gyemant G. Model for bβ-1, 6-N-acetylglucosamine oligomer hydrolysis catalysed by DispersinB, a biofilm degrading enzyme. Carbohydr Res 2012; 363: 7-13.
20. Munoz-Price LS, Poirel L, Bonomo RA et al. Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases. Lancet 2013; 13: 785-96.
21. Nordmann P, Cuzon G, Naas T. The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria. Lancet 2009; 9: 228-36.
22. Roux D, Danilchanka O, Guillard Tet al. Fitness cost of antibiotic susceptibility during bacterial infection. Sci Transl Med 2015; 7: 297ra114.
23. Poirel L, Pitout JD, Nordmann P. Carbapenemases: molecular diversity and clinical consequences. Future Microbiol 2007; 2: 501-12.
24. Walther-Rasmussen J, Hoiby N. Class A carbapenemases. J Antimicrob Chemother 2007; 60: 470-82.
25. Kumarasamy KK, Toleman MA, Walsh TR et al. Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancet 2010; 10: 597-602.
26. Doi Y, Paterson DL. Carbapenemase-producing Enterobacteriaceae. Semin Respir Crit Care Med 2015; 36: 74-84.
27. Maira-Litran T, Kropec A, Goldmann DA et al. Comparative opsonic and protective activities of Staphylococcus aureus conjugate vaccines containing native or deacetylated staphylococcal poly-N-acetyl-bβ-(1-6)-glucosamine. Infect Immun 2005; 73: 6752-62.
28. Poirel L, Potron A, Nordmann P. OXA-48-like carbapenemases: the phantom menace. J Antimicrob Chemother 2012; 67: 1597-606.
29. Chen KM, Chiang MK, Wang M et al. The role of pgaC in Klebsiella pneumoniae virulence and biofilm formation. Microb Pathog 2014; 77: 89-99.
30. Ye L, Zheng X, Zheng H. Effect of sypQ gene on poly-N-acetylglucosamine biosynthesis in Vibrio parahaemolyticus and its role in infection process. Glycobiology 2014; 24: 351-8.
31. Lin MH, Shu JC, Lin LP et al. Elucidating the crucial role of poly N-acetylglucosamine from Staphylococcus aureus in cellular adhesion and pathogenesis. PLoS One 2015; 10: e0124216.
32. Skurnik D, Roux D, Cattoir V et al. Enhanced in vivo fitness of carbapenem-resistant oprD mutants of Pseudomonas aeruginosa revealed through high-throughput sequencing. Proc Natl Acad Sci USA 2013; 110: 20747-52.
33. Vlock D, Lee JC, Kropec A et al. Pre-clinical and initial Phase I evaluations of a fully human monoclonal antibody directed against the PNAG surface polysaccharide on Staphylococcus aureus. In: Abstracts of the Fiftieth Interscience Conference on Antimicrobial Agents and Chemotherapy, Boston, MA, USA, 2010. Abstract G1-1654/329. American Society for Microbiology, Washington, DC, USA.